To evaluate the relationship between the PTEN gene and immunity in HCC patients, we first divided the PTEN high-expression and low-expression groups by the median expression level and then calculated the scores of 22 immune cells in the different groups. This evidence concerns the gene PTEN and hepatocellular carcinoma.